HIPERIKA sanum - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 304,547 | 315,026 | 294,978 | 477,178 | 597,118 | 706,171 | 708,181 | 764,881 |
| Profit before tax | 34,107 | 31,647 | 53,625 | 98,447 | 154,083 | 225,469 | 235,495 | 272,232 |
| Net profit | 28,991 | 26,788 | 45,582 | 83,680 | 130,971 | 259,289 | 200,171 | 228,675 |
| Equity | 41,983 | 68,771 | 114,353 | 198,036 | 329,007 | 520,655 | 720,826 | 949,500 |
| Liabilities | 35,938 | 26,287 | 51,044 | 56,518 | 59,618 | 45,701 | 0 | 52,779 |
| Non-current assets | 45,879 | 51,922 | 106,933 | 146,783 | 136,502 | 372,575 | 557,460 | 661,980 |
| Current assets | 32,042 | 43,136 | 58,464 | 107,771 | 252,123 | 193,781 | 207,737 | 340,299 |
| Total assets | 77,921 | 95,058 | 165,397 | 254,554 | 388,625 | 566,356 | 765,197 | 1,002,279 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 116,929 | 112,339 | 125,597 |
| Social insurance contributions | - | - | - | - | - | 85,135 | 87,647 | 93,598 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +36.3% | +3.4% | -6.4% | +61.8% | +25.1% | +18.3% | +0.3% | +8.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 37.2% | 28.2% | 27.6% | 32.9% | 33.7% | 45.8% | 26.2% | 22.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 69.1% | 39.0% | 39.9% | 42.3% | 39.8% | 49.8% | 27.8% | 24.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 9.5% | 8.5% | 15.5% | 17.5% | 21.9% | 36.7% | 28.3% | 29.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.2% | 10.0% | 18.2% | 20.6% | 25.8% | 31.9% | 33.3% | 35.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.4 | 0.4 | 0.3 | 0.2 | 0.1 | - | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,158 | 9,022 | 9,076 | 14,209 | 16,138 | 18,224 | 18,276 | 21,004 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
HIPERIKA sanum - Social security debts
The company had no debts to Sodra
HIPERIKA sanum - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-12-11 | 2025-12-15 | 43.41 |
| 2025-05-11 | 2025-05-13 | 565.0 |
| 2025-05-01 | 2025-05-10 | 569.65 |
| 2025-01-10 | 2025-01-15 | 370.57 |
| 2024-10-11 | 2024-10-15 | 309.26 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
HIPERIKA sanum, UAB (code 302802500) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €764.9K and net profit of €228.7K, with a profit margin of 29.9%. Revenue increased by 8.0% year on year and by 8.3% over two years, showing moderate but steady top-line growth. The profitability trend was mixed: net profit was €259.3K in 2023, declined to €200.2K in 2024, and recovered in 2025. The balance sheet also strengthened over the period. Total assets reached €1.00M in 2025, compared with €566.4K in 2023 and €765.2K in 2024, while equity rose to €949.5K and liabilities remained low at €52.8K. The equity ratio stood at 94.7%, debt-to-equity at 0.06, and asset turnover at 0.76x. Return on equity was 24.1% and return on assets 22.8%. Revenue per employee was €21.2K, with profit per employee of €6.4K.